← Back to Dashboard

HIV-1

Retroviridae · Lentivirus

Pandemic potential
36
Approved Drugs
4
Phase 3
18
Phase 2
48
Preclinical
106
Total Compounds

Antiviral Compounds

InosineHIV-1Stimulates cell-mediated immune response
Preclinical
—Viral RT
LopinavirHIV-1HIV protease inhibitor
FDA approved
FDAJapanRussia
Viral protease
NelfinavirHIV-1HIV protease inhibitor
FDA approved
FDAJapan
Viral protease
RitonavirHIV-1HIV protease inhibitor
FDA approved
FDAJapanRussia
Viral protease
TenofovirHIV-1Nucleotide analog RT inhibitor
FDA approved
FDAChinaRussia
Viral RT
RDEA806HIV-1—
Phase 2
——
islatravirHIV-1—
Phase 2
——
GSK2838232HIV-1—
Phase 2
——
cobicistatHIV-1—
Approved (other)
Japan
—
vorinostatHIV-1—
Phase 2
——
romidepsinHIV-1—
Phase 2
——
AMD11070HIV-1—
Phase 2
——
MethotrexateHIV-1—
Phase 2
——
amdoxovirHIV-1—
Phase 2
——
GSK3640254HIV-1—
Phase 2
——
GSK3532795HIV-1—
Phase 2
——
Tenofovir disoproxilHIV-1—
FDA approved
FDAJapanChina
—
Adefovir dipivoxilHIV-1—
FDA approved
FDAJapan
—
LenacapavirHIV-1—
FDA approved
FDAEMAJapan
—
AdefovirHIV-1Inhibits viral DNA synthesis
Phase 2
—Viral RT
AlisporivirHIV-1—
Preclinical
—Human CYPs
AmprenavirHIV-1Protease inhibitor
FDA approved
FDAJapan
Viral protease
AtazanavirHIV-1Protease inhibitor
FDA approved
FDAJapanRussia
Viral protease
AzacitidineHIV-1Nucleoside analog DNA methyl transferase inhibitor
Preclinical
—Viral RT
AzithromycinHIV-1—
Preclinical
—Human (multiple)
Showing 1 to 25 of 106 results
Page 1 of 5